Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Aaron Winn PhD
Assistant Professor
Department of School of Pharmacy Administration
Division of Administration

OFFICE ADDRESS:
Medical Education Building
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
2003 - 2007 Economics, University of Illinois at Chicago, Chicago, IL
2007 - 2009 MPP, University of Chicago, Chicago, IL
2013 - 2017 PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC

FACULTY APPOINTMENTS:
09/2017 - Present Assistant Professor, Clinical Sciences, School of Pharmacy, Medical College of Wisconsin

AWARDS AND HONORS:
2013 - 2017 Doctoral Fellowship, Royster Society of Fellows
2016 Student Travel Grant, Lineberger Cancer Center, University of North Carolina, Chapel Hill
2017 Best Abstract, AcademyHealth
2019 Highest Quality Peer Reviewer, Journal of Managed Care and Specialty Pharmacy
2019 Cost Effectiveness Analysis Registry Paper of the Year Award, The Tufts Medical Center, Center for the Evaluation of Value of Risk in Health

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
2015 - 2016 Journal of Clinical Oncology
2015 - Present American Journal of Preventative Medicine
2016 - Present Annals of Internal Medicine
2016 - 2017 North Carolina Journal of Medicine
2017 - Present Open Forum Infectious Diseases
2017 - Present Journal of Managed Care and Specialty Pharmacy
2017 - Present Clinical Breast Cancer
2018 - Present Cancer Causes & Control
2018 - Present The American Journal of Managed Care
2018 - Present Pharmacoepidemiology and Drug Safety
2018 - Present The Gerontologist
2018 - Present Cancer
2018 - Present Alzheimer's & Dementia
2018 - Present Journal of the National Cancer Institute
2019 - Present American Journal of Preventive Medicine
2019 - Present Journal of General Internal Medicine
2019 - Present Journal of the National Cancer Institute - Cancer Spectrum
2019 - Present Research in Social and Administrative Pharmacy
2019 - Present Value in Health
2019 - Present Journal of the American Pharmacists Association
2020 - Present Journal of the American Medical Informatics Association
2020 - Present Clinical Epidemiology
2020 - Present Patient Preference and Adherence

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2020 - Present Member, ESAS Nominations/Awards Committee, APhA

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Using Big Data Informatics to Improve Care of Women with Advance Breast Cancer
Source:
Advancing a Healthier Wisconsin and the CTSI
Role:
PI
PI:
Winn
Dates:
08/01/2018 - 07/31/2020
Direct Funds:
$250,000
 
Title:
Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes
Source:
National Institute on Minority Health and Health Disparities
Role:
Investigator
PI:
Laiteerapong (University of Chicago)
Dates:
2019 - 2022
Direct Funds:
$415,465
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
Winn, Aaron, The Role of Social Networks in the Receipt of Industry Payments, Health Economics Workshop at the University of Chicago, 2018
Winn, Aaron, Understanding the Role of Patient Costs In Use and Adherence to High Value Cancer Medications, Chronic Diseases & Medical Decision Making, University of Chicago, 08/2020
Winn, Aaron, The Effect of Health System Factors on Vulnerable Populations, Division of Pharmaceutical Outcomes and Policy Seminar at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, 2020
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
Local
Winn AN, Mitchell A, Fergestrom N, Neuner JM, Trogdon J, The Role of Physician Social Networks in Receipt of Pharmaceutical Industry Payments, Milwaukee Regional Research Forum, Milwaukee, WI, 2018
 
National
Huang E, Winn AN, John P, Chin M, Meltzer D, The impact of baseline health status on the prioritization of intensive control of glucose and blood pressure levels in elderly patients with diabetes, Society for Medical Decision Making, 2008
Winn AN, John P, Sarkisian C, Meltzer D, Huang E, The Association of Expectations Regarding Aging and Diabetes-Related Utilities, American Geriatrics Society, 2009
Huang ES, Greeley S, John P, Winn AN, Ornelas J, ,Lipton R, Bell G, and Philipson L, Society of Medical Decision Making, 2010
Winn, AN, O’Grady, M, John P, Substantial Medicare Savings May Result If Insurers Cover ‘Artificial Pancreas’ Sooner For Diabetes Patients, AcademyHealth, 2011
Olchanski N, Winn AN, Cohen JT, Neumann PJ, Abdominal Aortic Aneurysm Screening: The Impact of the SAAAVE Act of 2007, AcademyHealth, 2013
Lin PJ, Cohen JT, Winn A, Kent DM, Neumann PJ, Patterns of Comorbidity Clusters Among Adults with Diabetes, AcademyHealth, 2013
Olchanski N, Winn AN, Cohen JT, Neumann PJ, Abdominal Aortic Aneurysm Screening: How Many Life Years Lost From Underuse of the Medicare Screening Benefit?, AcademyHealth, 2013
Shah G, Winn AN, Cohen J, Lin P, Parsons S, Survival benefit and cost of autologous hematopoietic stem cell transplantation (Auto HSCT) in elderly patients with multiple myeloma (MM) using the SEER-Medicare database., American Society of Clinical Oncology, 2014
Shah G, Winn AN, Cohen J, Lin P, Parsons S., Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database, American Society of Hematology, 2014
Winn AN, Dusetzina SB, Importance of Capturing Longitudinal Adherence Trajectories: Mortality and Adherence to Hormonal Therapy Among Women with Breast Cancer, AcademyHealth, 2015
Olchanski N, Winn AN, Zhang Y, The Development, Calibration, and Validation of the US Population Health Microsimulation Model, Society of Medical Decision Making, 2016
Winn AN, Dusetzina SB, Factors Associated with Tyrosine Kinase Inhibitors Initiation and Adherence among Medicare Beneficiaries with Chronic Myeloid Leukemia, AcademyHealth, 2016
Olchanski N, Winn AN, Zhang Y, Cohen J, A Simulation Approach to Population Health: The Development and Validation of the US Population Health Microsimulation Model, AcademyHealth, 2016
Shah GL, Winn AN, Lin PJ, Kumar AJ, Parsons SK, Comparison of Survival and Costs of Rituximab-Based Chemotherapy for Initial Therapy of Follicular Lymphoma in Elderly Patients, American Society of Hematology, 2016
Dusetzina SB, Huskamp H, Winn AN, Basch E, Keating N, The Impact of State Chemotherapy Laws on Use and Spending for Oral Chemotherapy, AcademyHealth, 2016
Shah GL, Winn AN, Lin PJ, Kumar AJ, Parsons SK, The Utility of the Charlson Comorbidity Index in Predicting Use of Treatment and Survival in Older Lymphoma Patients, American Society of Hematology, 2016
Mitchell A, Winn AN, and Dusetzina SB, Pharmaceutical Industry Payments and Physician Drug Selection in Oncology, AcademyHealth, 2017
Winn AN, Dusetzina SB, Winn AN, Dusetzina SB. Paying More for the Same Care: Comparing Physician Office and Hospital Outpatient Department Spending for Infused Chemotherapy among Privately Insured Patients., AcademyHealth, 2017
Mitchell A, Winn AN, and Dusetzina SB, Pharmaceutical Industry Payments and Physician Drug Selection in Oncology, American Society of Clinical Oncology, 2017
Winn AN, Keating NL, Trogdon JG, Basch EM, Dusetzina SB, Association between Chemotherapy Provider Competition and Access, Cost and Quality of Care for Medicare Beneficiaries with Cancer, Annual Conference of the American Society of Health Economist (ASHEcon), Atlanta, GA, 2018
Roberts A, Neuner, JM, Fergestrom N, Winn AN, New onset persistent opioid use among older adult breast cancer survivors, American Pharmacists Association (APhA) Annual Meeting & Exposition, Seattle, WA, 2019
Winn AN, Fergestrom NM, Neuner JM, The Impact of Reduced Copays on Primary and Secondary Adherence to Hormonal Therapy for Older Breast Cancer Patients: Multi-State Analysis, 41st Annual Meeting of the Society for Medical Decision Making, Portland, OR, 2019
Winn AN, Karter AJ, Staab EM, Liu J, Wan W, Skandari R, Knitter AC, Moffet HM, Miller DR, Peek ME, Huang ES, Laiteerapong N, Racial Difference in Diabetes Medication Initiation, American Diabetes Association Annual Meeting, Virtual, 2020
 
International
Lin PJ, Cohen JT, Winn AN, Kent DM, Neumann PJ., Patterns of Comorbidity Clusters Among Adults with Diabetes, International Society for Pharmacoeconomics and Outcomes Research, 2013
Lin P, Olchanski N, Winn AN, Lang K, Using EMR Data for Conducting Retrospective Studies: Opportunities and Pitfalls, International Society for Pharmacoeconomics and Outcomes Research, 2013
Winn AN, Neumann PJ, Cost-Effectiveness of FDA-Approved Cancer Drugs Since 2000, of International Society for Pharmacoeconomics and Outcomes Research, 2013
Cangelosi MJ, Zhong Y, Winn A, Chambers JD, Value-Based Insurance Desing Informed By Government Research: A Case Study of Osteoporosis Fractures, International Society for Pharmacoeconomics and Outcomes Research, 2013
Olchanski N, Winn AN, Cohen JT, Neumann PJ, Abdominal Aortic Aneurysm Screening: How Many Life Years Lost From Underuse of the Medicare Screening Benefit?, International Meeting of International Society for Pharmacoeconomics and Outcomes Research, 2013
Chambers JD, Pyo J, Winn A, Neumann PJ, A Systematic Review of the Network Meta-Analysis Literature, International Society for Pharmacoeconomics and Outcomes Research, 2013
Olchanski N, Zhong Y, Winn AN, Terrin N, Cohen JT, Neumann PJ, Population Health Model: Projecting Health Trajectory of the Massachusetts Population, International Society for Pharmacoeconomics and Outcomes Research, 2014
Winn AN, Lin P, Cohen J, Parsons S, Cost-effectiveness Analysis of Innovation in Hematologic Malignancies, International Society for Pharmacoeconomics and Outcomes Research, 2014
Saret C, Winn AN, Cohen J, Lin P, Shah G, Parsons S, Value of Innovation in leukemia, Lymphoma and Myeloma: A Systematic Review, International Society for Pharmacoeconomics and Outcomes Research, 2014
Zhong Y, Lin PJ, Winn A, Cohen JT, Neumann PJ, Cost-utility Analyses in Diabetes: A Systematic Review and Potential Gains from Using Economic Evidence, International Society for Pharmacoeconomics and Outcomes Research, 2014
Dusetzina SB, Winn AN, Taking Medication Adherence Personally: What Does Prior Adherence Tell Us about Future Adherence?, International Conference on Pharmacoepidemology and Therapeutic Risk Management, 2015
Winn AN, Dusetzina SB, Improving Adherence Measurement for Applied Pharmacoepidemiology: Estimating the Association between Endocrine Therapy Adherence and Mortality among Women with Breast Cancer, International Conference on Pharmacoepidemology and Therapeutic Risk Management, 2015
Winn AN, Dusetzina S, Multi-State Models – A Complimentary Approach to Group Based Trajectory Models, International Conference on Pharmacoepidemology and Therapeutic Risk Management, 2016
Kumar AJ, Winn AN, Lin PJ, Shah GL, Parsons SK, . Enrollment Patterns for Hospice and Cost of End-of-Life Care Among Elderly Patients with Diffuse Large B-cell Lymphoma: A SEER-Medicare Analysis, International Meeting of International Society for Pharmacoeconomics and Outcomes Research, 2016
Kumar AJ, Winn AN, Lin PJ, Shah GL, Parsons SK, Cost-Effectiveness of Rituximab-based Chemotherapy Combinations for the Initial Therapy of Follicular Lymphoma, International Society for Pharmacoeconomics and Outcomes Research, 2016
Winn AN, Fergestrom N, Neuner JM, Using Group Based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: the Case Study of Generic Hormonal Therapy for Women With Breast Cancer, International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Prague, Czech Republic, 2018
Winn AN, Fergestrom N, Neuner JM, Trogdon J, The Role Of Physician Social Networks in Receipt of Pharmaceutical Payments, International Health Economics Association World Congress, Basel, Switzerland, 2019
Winn AN, Fergestrom NM, Nuener JM, The Impact of Reduced Copay for Hormonal Therapy on Primary and Secondary NonAdherence for Breast Cancer Medicare Patients, 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Philadelphia, PA, 2019
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2017 - 2018 Member, Assessment, School of Pharmacy
2017 - Present Member, Faculty Council
2018 - Present Chair, Assessment, School of Pharmacy
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Pharmacy Student Education
2017 - Present Course Director: Population Health
2017 - Present Course Director: Evidence Based Practice
2018 - Present Course Director: Health Systems and Patient Safety
 

PROGRAMMATIC DEVELOPMENTS:
 
Research Programs
09/2018 - 08/2020 CTSI of Southeast Wisconsin, Clinical Research Scholars Program
 
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Williams D Jr, Lawrence J, Hong YR, Winn A. Tele-ICUs for COVID-19: A Look at National Prevalence and Characteristics of Hospitals Providing Teleintensive Care. J Rural Health. 2020 Oct 08.
2. Holt JM, Winn A, Cusatis R, Talsma A, Crotty BH. Racial Disparities in Patient Activation: The Role of Economic Diversity. West J Nurs Res. 2020 Oct 05:193945920963130.
3. Winn AN, Check DK, Farkas A, Fergestrom NM, Neuner JM, Roberts AW. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer. JAMA Netw Open. 2020 Sep 01;3(9):e2016858. PMCID: PMC7492912
4. Holt JM, Cusatis R, Winn A, Asan O, Spanbauer C, Williams JS, Flynn KE, Somai M, Laud P, Crotty BH. The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Sep 23;9(9):e20309.
5. Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW. Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer. J Natl Cancer Inst. 2020 Jul 01;112(7):765-768. PMCID: PMC7357325
6. Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM. The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence. Pharmacoepidemiol Drug Saf. 2020 05;29(5):550-557.
7. Dusetzina SB, Huskamp HA, Jazowski SA, Winn AN, Wood WA, Olszewski A, Basch E, Keating NL. Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers. J Natl Cancer Inst. 2020 Oct 01;112(10):1055-1062.
8. Winn AN, Somai M, Fergestrom N, Crotty BH. Association of Use of Online Symptom Checkers With Patients' Plans for Seeking Care. JAMA Netw Open. 2019 12 02;2(12):e1918561. PMCID: PMC6991310
9. Roberts AW, Fergestrom N, Neuner JM, Winn AN. New-onset persistent opioid use following breast cancer treatment in older adult women. Cancer. 2020 02 15;126(4):814-822. PMCID: PMC6994182
10. Kochar B, Jiang Y, Winn A, Barnes EL, Martin CF, Long MD, Kappelman MD. The Early Experience With Vedolizumab in the United States. Crohns Colitis 360. 2019 Oct;1(3):otz027. PMCID: PMC6798787
11. Winn AN, Maciejewski ML, Dusetzina SB. Identifying Heterogeneous Treatment Effects of Drug Policy in Quasi-experimental Settings. Current Epidemiology Reports. 2019:1-7.
12. Crotty BH, Winn AN, Asan O, Nagavally S, Walker RJ, Egede LE. Clinician Encouragement and Online Health Record Usage. J Gen Intern Med. 2019 11;34(11):2345-2347. PMCID: PMC6848784
13. Doll KM, Winn AN. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis. Am J Obstet Gynecol. 2019 10;221(4):318.e1-318.e9.
14. Mitchell AP, Winn AN, Lund JL, Dusetzina SB. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology. Oncologist. 2019 05;24(5):632-639. PMCID: PMC6516135
15. Winn AN, Fergestrom NM, Neuner JM. Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer. Med Care. 2019 01;57(1):85-93. PMCID: PMC6291347
16. Drangsholt S, Walter D, Ciprut S, Lepor A, Sedlander E, Curnyn C, Loeb S, Malloy P, Winn AN, Makarov DV. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer. Urol Oncol. 2019 02;37(2):145-149.
17. Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O'Grady M, Huang ES. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 2018 11;38(8):942-953. PMCID: PMC6226055
18. Wan W, Skandari MR, Minc A, Nathan AG, Winn A, Zarei P, O'Grady M, Huang ES. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06;41(6):1227-1234. PMCID: PMC5961392
19. Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. JAMA Intern Med. 2018 06 01;178(6):854-856. PMCID: PMC6145757
20. Winn AN, Keating NL, Trogdon JG, Basch EM, Dusetzina SB. Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014. JAMA Oncol. 2018 Apr 01;4(4):580-581. PMCID: PMC5885220
21. Laiteerapong N, Cooper JM, Skandari MR, Clarke PM, Winn AN, Naylor RN, Huang ES. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06;168(3):170-178. PMCID: PMC5989575
22. Dusetzina SB, Huskamp HA, Winn AN, Basch E, Keating NL. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws. JAMA Oncol. 2018 06 14;4(6):e173598. PMCID: PMC6054307
23. Anderson C, Winn AN, Dusetzina SB, Nichols HB. Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ. J Cancer Epidemiol. 2017;2017:6091709. PMCID: PMC5615957
24. Jazowski SA, Winn AN. The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care. Curr Diab Rep. 2017 06;17(6):40.
25. Chou YT, Winn AN, Rosenstein DL, Dusetzina SB. Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis. Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):676-684. PMCID: PMC5457339
26. Doll KM, Winn AN, Goff BA. Untangling the Black-White mortality gap in endometrial cancer: a cohort simulation. Am J Obstet Gynecol. 2017 03;216(3):324-325.
27. Winn AN, Keating NL, Dusetzina SB. Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia. J Clin Oncol. 2016 12 20;34(36):4323-4328. PMCID: PMC5455309
28. Sullivan SA, Clark LH, Staley AS, Tran AQ, Winn A, Kim KH. Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications. Gynecol Oncol. 2017 Feb;144(2):294-298.
29. Shah GL, Winn A, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK. Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare. Bone Marrow Res. 2016;2016:3645623. PMCID: PMC5088316
30. Gennetian, L, Seshadri, R, Hess, N, Winn, AN, Goerge, R. Supplemental Nutrition Assistance Program (SNAP) Benefit Cycles and Student Disciplinary Infractions Social Service Review. 90(3): 403-433. .
31. Aarnio E, Martikainen J, Winn AN, Huupponen R, Vahtera J, Korhonen MJ. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter? Circ Cardiovasc Qual Outcomes. 2016 11;9(6):704-713.
32. Winn AN, Dusetzina SB. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer. Pharmacoepidemiol Drug Saf. 2016 08;25(8):953-9.
33. Lin PJ, Winn AN, Parsons SK, Neumann PJ, Weiss ES, Cohen JT. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007. Med Care. 2016 Apr;54(4):380-5.
34. Winn AN, Ekwueme DU, Guy GP Jr, Neumann PJ. Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review. Am J Prev Med. 2016 Feb;50(2):241-8. PMCID: PMC5846573
35. Dusetzina SB, Ellis S, Freedman RA, Conti RM, Winn AN, Chambers JD, Alexander GC, Huskamp HA, Keating NL. How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab. J Oncol Pract. 2015 Jul;11(4):313-8. PMCID: PMC4507391
36. Shah GL, Winn AN, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK. Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database. Biol Blood Marrow Transplant. 2015 Oct;21(10):1823-9. PMCID: PMC4933291
37. Winn AN, Shah GL, Cohen JT, Lin PJ, Parsons SK. The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. J Natl Cancer Inst. 2015 Aug;107(8). PMCID: PMC4554189
38. Chambers JD, Naci H, Wouters OJ, Pyo J, Gunjal S, Kennedy IR, Hoey MG, Winn A, Neumann PJ. An assessment of the methodological quality of published network meta-analyses: a systematic review. PLoS One. 2015;10(4):e0121715. PMCID: PMC4414531
39. Lin PJ, Kent DM, Winn A, Cohen JT, Neumann PJ. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care. 2015 Jan 01;21(1):e23-34.
40. Zhong Y, Lin PJ, Cohen JT, Winn AN, Neumann PJ. Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence. Value Health. 2015 Mar;18(2):308-14.
41. Saret CJ, Winn AN, Shah G, Parsons SK, Lin PJ, Cohen JT, Neumann PJ. Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses. Blood. 2015 Mar 19;125(12):1866-9. PMCID: PMC4366623
42. Chambers JD, Winn A, Zhong Y, Olchanski N, Cangelosi MJ. Potential role of network meta-analysis in value-based insurance design. Am J Manag Care. 2014 Aug;20(8):641-8.
43. Olchanski N, Winn A, Cohen JT, Neumann PJ. Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit? J Gen Intern Med. 2014 Aug;29(8):1155-61. PMCID: PMC4099445
44. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014 Feb 01;32(4):306-11.
45. Naylor RN, John PM, Winn AN, Carmody D, Greeley SA, Philipson LH, Bell GI, Huang ES. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014;37(1):202-9. PMCID: PMC3867988
46. O'Grady MJ, John P, Winn A. Substantial Medicare savings may result if insurers cover 'artificial pancreas' sooner for diabetes patients. Health Aff (Millwood). 2012 Aug;31(8):1822-9.
47. Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES, JDRF Continuous Glucose Monitoring Study Group. Health utilities for children and adults with type 1 diabetes. Med Care. 2011 Oct;49(10):924-31. PMCID: PMC3210197
48. Greeley SA, John PM, Winn AN, Ornelas J, Lipton RB, Philipson LH, Bell GI, Huang ES. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar;34(3):622-7. PMCID: PMC3041194
49. Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2010 Jun;33(6):1269-74. PMCID: PMC2875436
 
Editorials, Letters to Editor, Other
1. Winn AN, Dusetzina SB. More evidence on the limited impact of state oral oncology parity laws. Cancer. 2019 02 01;125(3):335-336. PMCID: PMC6361375
2. Winn AN, Neuner JM. Making Sure We Don't Forget the Basics When Using Machine Learning. J Natl Cancer Inst. 2019 Jun 01;111(6):529-530.
3. Winn AN, Keating NL, Dusetzina SB. Reply to E. Ritchie et al. J Clin Oncol. 2017 05 20;35(15):1745-1746.
4. Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW. Response to Strassels and Durham. J Natl Cancer Inst. 2020 Sep 21.
 

jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a